Leyenda
: Ensayo clínico en reclutamiento
= 
; Ensayos clínico en curso
= 
-
- A phase I/II multicentre study of autologous stem cell transplantation followed by nonmyeloablative allogeneic stem cell transplantation for patients with relapsed or refractory Lymphoma
- Universitätsklinikum Leipzig AöR
- Abteilung Hämatologie, Internistische Onkologie und Hämostaseologie
- Para más detalles
-
- FRANCIA
- ILE-DE-FRANCE
- VILLEJUIF
- (APL-A-005-02) Phase I - II clinical and pharmacokinetic study of Aplidin (APL) as a 3-hour intravenous infusion every 2 weeks, in children with refractory or relapsed malignant tumours and leukaemia -Terminated -
- CRLCC Institut de cancérologie Gustave Roussy
- Département de cancérologie de l'enfant et de l'adolescent
- Para más detalles
-
- FRANCIA
- RHONE-ALPES
- NOT YET IDENTIFIED - FR
- Phase I Dose-Escalation, Pharmacokinetic and Pharmacodynamic Study of Debio 0932, a Novel HSP90-Inhibitor, Administered Orally, in Patients with Advanced Solid Tumours or Lymphoma - FR
- Not yet identified - FR
- Para más detalles
-
- REINO UNIDO (EL)
- Greater Manchester
- MANCHESTER
- APL-A-005-02: Phase I - II clinical and pharmacokinetic study of Aplidin (APL) as a 3-hour intravenous infusion every 2 weeks, in children with refractory or relapsed malignant tumours and leukaemia
- Royal Manchester Children's Hospital
- Department of Paediatric Oncology
- Para más detalles
